Skip to content

Evaluation of Health Effects of a First Time Marathon in Young Middle-Aged men

Evaluation of Health Effects of a First Time Marathon in Young Middle-Aged men

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON20364
Enrollment
24
Registered
2020-03-11
Start date
2021-03-01
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy first time marathon runners

Interventions

None listed

Sponsors

AMC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: · Men aged between 35-50 · No known (uncontrolled) medical illness · Has no history of surgery for the past 2 years · Does not suffer from musculoskeletal injury · Has not run or trained for a marathon before · Has not run further than 21.1 km in one single race or training in the last year · Has never trained or competed on a semi-professional or professional level in endurance sports · Agree and signed the informed consent to participate in this study Subgroup: If possible, we will aim to include 12 participants (half of study sample) with a documented covid 19 history (PCR positive) without hospitalization for the past 6 months.

Exclusion criteria

Exclusion criteria: · Classified as high risk (symptomatic, or known cardiovascular, pulmonary, renal or metabolic disease) according to ACSM guideline · Contraindications for MRI scanning (claustrophobia or other contra-indication for MRI) · Glomerular filtration rate < 30 ml/min · Illiterate or unable to provide written informed consent

Design outcomes

Primary

MeasureTime frame
MRI characterization of myocardial (mal)adaptation of marathon training and participation as assessed by left and right ventricular end-diastolic and end-systolic volumes (with the corresponding stroke volumes and ejections fractions), mass and wall thickness.

Secondary

MeasureTime frame
· Echocardiography: The functions of cardiac systolic, diastolic, left ventricle, right ventricle, valves and dimensions · ECG: Detection any ECG abnormalities · CPET: VO2max · Heart rate: Exercise intensity, resting heart rate · Cardiac biomarkers: Troponin I and T, N-T pro BNP, CT-1 and Galectin-3 · Cardiomyocyte integrity: LGE, mean diffusivity (MD), extracellular volume fraction (ECV)

Contacts

Public ContactInarota Laily

Amsterdam Medisch Centrum

i.laily@amsterdamumc.nl0204444010

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)